Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD

American Journal of Psychiatry

Volumn 169, Issue 2, 2012, Pages 167-177

  Vitiello, Benedetto ^a   Elliott, Glen R ^b   Swanson, James M ^c   Arnold, L Eugene ^d   Hechtman, Lily ^e   Abikoff, Howard ^f   Molina, Brooke S G ^g   Wells, Karen ^h   Wigal, Timothy ^c   Jensen, Peter S ⁱ   Greenhill, Laurence L ^j   Kaltman, Jonathan R ^k   Severe, Joanne B ^a   Odbert, Carol ^a   Hur, Kwan ^l   Gibbons, Robert ^m  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Children's Health Council   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f NEW YORK UNIVERSITY   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ REsource for Advancing Children's Health   (United States)

^j NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^l UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^m UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; MOOD STABILIZER; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADRENERGIC ACTIVITY; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RESPONSE; CHILD; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; GROUP THERAPY; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREHYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT DURATION;

EID: 84856004996     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10111705     Document Type: Article

References (39)

1. Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM: Cardiovascular effects of methylphenidate in humans are associated w ith increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl) 2003; 166:264-270 (Pubitemid 36384773)
2. Ballard JE, Boileau RA, Sleator EK, Massey BH, Sprague RL: Cardiovascular responses of hyperactive children to methylphenidate. JAMA 1976; 236:2870-2874 (Pubitemid 8011723)
3. Findling RL, Short EJ, Manos MJ: Short-term cardiovascular effects of methylphenidate and Adderall. J Am Acad Child Adolesc Psychiatry 2001; 40:525-529 (Pubitemid 32374269)
4. Wilens TE, Biederman J, Lerner M; Concerta Study Group: Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study. J Clin Psychopharmacol 2004; 24:36-41 (Pubitemid 38134164)
5. Samuels JA, Franco K, Wan F, Sorof JM: Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 2006; 21:92-95 (Pubitemid 43040200)
6. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T: A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 2006; 59:829-835
7. Stowe CD, Gardner SF, Gist CC, Schulz EG, Wells TG: 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy. Ann Pharmacother 2002; 36:1142-1149 (Pubitemid 34755788)
8. Findling RL, Biederman J, Wilens TE, Spencer TJ, McGough JJ, Lopez FA, Tulloch SJ: Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr 2005; 147:348-354 (Pubitemid 41348714)
9. Safer D: Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 1992; 2:279-290
10. Hammerness P, Wilens T, Mick E, Spencer T, Doyle R, McCreary M, Becker J, Biederman J: Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. J Pediatr 2009; 155:84-89
11. Donner R, Michaels MA, Ambrosini PJ: Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61:706-712 (Pubitemid 46328853)
12. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, Greenland P: Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med 2001; 161:1501-1508 (Pubitemid 32679562)
13. Nissen S: ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354:1445-1448
14. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Richters JE, Schiller E, Severe JB, Swanson JM, Vereen D, Wells KC: National Institute of Mental Health Collaborative Multimodal Treatment Study of Children With ADHD (the MTA): design, challenges, and choices. Arch Gen Psychiatry 1997; 54:865-870 (Pubitemid 27383314)
15. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999; 56:1073-1086
16. Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T: Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry 2001; 40:180-187 (Pubitemid 32111021)
17. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND; MTA Cooperative Group: Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 2007; 46:1014-1026
18. Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR; MTA Cooperative Group: The MTA at 8 years: prospective follow-up of children treated for combined type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009; 48:484-500
19. MTA Cooperative Group: National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113:754-761
20. Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein O, Elliott GR, Hechtman L, Jensen PS, Hinshaw SP, March JS, Newcorn JH, Swanson JM, Cantwell DP: Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry 2001; 40:188-196 (Pubitemid 32111022)
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, National Heart, Blood and Lung Institute: The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114:555-576
22. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 2002; 11:1-190
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572 (Pubitemid 37430158)
24. Bernstein D: The cardiovascular system, in Nelson Textbook of Pediatrics, 16th ed. Edited by Behrman RE, Kliegman RM, Jensen HB. Philadelphia, WB Saunders, 2000
25. Arnold LE, Christopher J, Huesti R, Smeltzer DJ: Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction. Arch Gen Psychiatry 1978; 35:463-473
26. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA: Heart disease and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113:1489-1494 (Pubitemid 17092823)
27. Gillum RF, Makuc DM, Feldman JJ: Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-Up Study. Am Heart J 1991; 121:172-177
28. Jouven X, Empana JP, Escolano S, Buyck JF, Tafflet M, Desnos M, Ducimetiere P: Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. Am J Cardiol 2009; 103:279-283
29. Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM: Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J 2010; 159:612-619
30. Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A: Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 2007; 120:e1494-e1501
31. Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992-1001
32. Vitiello B, Towbin K: Stimulant treatment of ADHD and risk of sudden death in children. Am J Psychiatry 2009; 166:955-957
33. McNeil Pharmaceuticals: Concerta Prescribing Information. Revised Nov 2009. http://www.concerta.net/assets/Prescribing-Info-short.pdf
34. Berger S, Utech L, Fran Hazinski M: Sudden death in children and adolescents. Pediatr Clin North Am 2004; 51:1653-1677 (Pubitemid 39550508)
35. Anderson KP: Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances. Ann Noninvasive Electrocardiol 2003; 8:75-89 (Pubitemid 38569956)
36. Terai H, Shimizu M, Ino H, Yamaguchi M, Hayashi K, Sakata K, Kiyama M, Hayashi T, Inoue M, Taki J, Mabuchi H: Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachiarrthythmias. J Nucl Cardiol 2003; 10:304-310 (Pubitemid 36758076)
37. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ: Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004; 113:475-482 (Pubitemid 38280786)
38. Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206 (Pubitemid 37430058)
39. Muntner P, Jiang He, Cutler JA, Widman RP, Whelton PK: Trends in blood pressure among children and adolescents. JAMA 2004; 291:2107-2113 (Pubitemid 38580154)